Virtus ETF Advisers LLC Compugen LTD Transaction History

Virtus ETF Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.57 - $3.33 $59,517 - $126,236	-37,909 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $6,215 - $10,449	-2,252 Reduced 5.61%	37,909 $122,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $62,094 - $108,703	15,182 Added 60.78%	40,161 $173,000
Q3 2021 Nov 15, 2021	SELL	$5.8 - $8.02 $7,574 - $10,474	-1,306 Reduced 4.97%	24,979 $149,000
Q2 2021 Aug 10, 2021	BUY	$6.87 - $9.16 $20,946 - $27,928	3,049 Added 13.12%	26,285 $218,000
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $3,083 - $5,535	402 Added 1.76%	23,236 $200,000
Q4 2020 Feb 12, 2021	BUY	$12.07 - $17.95 $8,267 - $12,295	685 Added 3.09%	22,834 $277,000
Q3 2020 Nov 13, 2020	SELL	$14.16 - $19.45 $42,862 - $58,875	-3,027 Reduced 12.02%	22,149 $360,000
Q2 2020 Aug 05, 2020	BUY	$6.97 - $17.12 $175,476 - $431,013	25,176 New	25,176 $378,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.